ArticleRespirology case reports2025
A Rare and Challenging Presentation of an Inflammatory Myofibroblastic Tumour: A Case Report.
Article in Respirology case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Inflammatory Myofibroblastic Tumours (IMTs) are rare pulmonary neoplasms, accounting for less than 1% of lung tumours. Patients present with non-specific symptoms and diverse radiological findings. A 32-year-old female presented with progressively worsening cough, haemoptysis, low-grade fever and increasing shortness of breath. Chest X-ray revealed a total right lung collapse. Further imaging revealed a mass obstructing the right mainstem bronchus. A staged debulking procedure using rigid bronchoscopy was performed, followed by the insertion of a silicone stent to maintain airway patency. Endobronchial growth turned out to be an Inflammatory Myofibroblastic tumour. The patient showed significant improvement in respiratory function and lung re-expansion. Adjuvant therapy with ALK inhibitor was initiated. IMTs, while benign histologically, may recur or metastasise, requiring long-term monitoring. Bronchoscopic interventions offer effective treatment for localised disease, while surgery is preferred for extensive tumours. Early diagnosis, genetic profiling and a multidisciplinary approach are key for optimal outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.